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Background: In this study, we have investigated the effect of 
Korean red ginseng (KRG) extracts on the production of 
TNF-α and IL-8 in human keratinocytes. Also, to examine 
the antioxidative effect of red ginseng extracts, free radical 
scavenging activity and superoxide dismutase (SOD) activity 
in human dermal fibroblasts was measured. Methods: To in-
vestigate the effect of KRG in atopic dermatitis, we meas-
ured the level of TNF-α  and IL-8 secretion in LPS-stimulated 
human keratinocytes after the treatment of KRG extracts us-
ing enzyme-linked immunosorbent assay. Anti-oxidative ac-
tivity was investigated by measuring 1,1-diphenyl-2-picrylhy-
drazyl (DPPH) radical scavenging and SOD activity. Results: 
The stimulation of human keratinocytes with KRG extracts 
shifted the LPS-induced cytokine secretion toward a more 
immunosuppressive response. KRG dose-dependently de-
creased TNF-α  and IL-8 production in HaCaT cells and a sig-
nificant inhibition of TNF-α was shown when cells were 
treated with 500 and 1,000μg/ml of KRG extracts. Additio-
nally, KRG extracts showed DPPH radical scavenging and 
SOD activity in a dose-dependent manner. Particularly, SOD 
activities of concentrations higher than 60μg/ml of KRG ex-
tracts were significantly different in human dermal fibroblast 
cells. Conclusion: Based on this study, KRG extracts may be 




All parts of the atopic disease have shown an increase in the 
last few decades (1). The first clinical manifestation of atopy 
is generally considered atopic dermatitis and the start of the 
atopic march. The atopic march is generally characterized by 
the progression of atopic dermatitis to asthma and allergic rhi-
nitis during the first several years of life. The putative mecha-
nism is the skin, which acts as the site of primary sensitization 
through possible defects in the epidermal barrier with later 
sensitization in the airways (2,3). Atopic dermatitis correlates 
with the expression of proinflammatory cytokines such as tu-
mor  necrosis  factor-alpha  (TNF-α),  interleukin  (IL)-8,  and 
IL-1 from keratinocytes, mast cells, and denderitic cells. Acute 
AD is associated with the production of T helper 2 type (Th2) 
cytokines but during chronic phase of AD, there is a switch 
to Th1-like cells which primarily produce TNF-α and IFN-γ 
(4).
    Keratinocytes comprise 90% of the cells found in the epi-
dermis and are capable of eliciting an immune response (5). 
Cytokines produced by these epithelial cells maintain normal 
homeostatic  mechanisms  in  these  structures.  Skin  cytokines 
can have pro-inflammatory as well as anti-inflammatory func-
tion, and dysfunction in the cytokine balances can contribute 
to inflammatory diseases in these organ systems (6). Keratino-
cytes synthesize and secrete a wide variety of cytokines in-
cluding tumor TNF-α and IL-8. TNF-α is an important medi-
ator of shock and cachexia (7). TNF-α induces fever, hypo-
tension, prostaglandin E2 (PGE 2), and local tissue necrosis (8). 
It also has a synergistic effect on PGE2-induced aggregation 
of neutrophils and synthesis of thromboxanes (6). In addition, 
IL-8 is a potent neutrophil chemoattractant and activating fac-Effects of Korean Red Ginseng
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tor produced by a variety of cells including keratinocytes and 
its production is augmented by the primary cytokine TNF-α 
(9).  Intradermally  injected  IL-8  induces  neutrophil  accumu-
lation in dermis surrounding the dermal blood vessels (10). 
Overexpression of IL-8 is also thought to mediate T-cell che-
moattraction in cutaneous T-cell lymphoma (11) and to con-
tribute to neutrophil accumulation in the epidermis in psori-
atic  skin  (12).
    Moreover, antioxidants may be beneficial in conditions of 
oxidative stress, defined as when the oxidative/reductive bal-
ance  of  the  body  is  tipped  in  favor  of  the  former  (13). 
Reactive  oxygen  species  (ROS)  released  from  inflammatory 
cells  constitutes  one  of  the  critical  causative  factors  in  in-
flammatory  skin  diseases  such  as  atopic  dermatitis  (14). 
Several types of inflammatory cells such as neutrophils and 
macrophages  play  an  important  role  in  acute  inflammatory 
processes.  However,  in  chronic  and  overaggressive  in-
flammatory conditions, ROS may also be released into the ex-
tracellular compartment, and may cause local propagation of 
the  inflammatory  reaction  and  tissue  damage  (15,16). 
Therefore, the inhibition of ROS production or scavenging the 
released ROS may be important in preventing excess tissue 
damage  in  atopic  dermatitis  (14).
    To treat atopic dermatitis, anti-inflammatory agents are of-
ten  applied.  Topical  corticosteroids  as  anti-inflammatory 
agents rapidly reduce the severity of this disease, but allow 
early relapse of the dermatitis after discontinuing treatment. 
In addition, chronic use of stronger steroids may lead to a 
rebound phenomenon, steroid dermatitis, and rosacea-like le-
sions (17). Traditional herbs is an alternative therapy that can 
be used in the treatment of dermatologic disorders (18,19). 
Previous studies have shown that herbal therapy with oriental 
medicine may be beneficial for the treatment of patients with 
atopic dermatitis (20). Korean red ginseng (KRG, the steamed 
root of panax ginseng C. A. Meyer) is a well known tradi-
tional medicinal remedy used in Asian countries as well as 
in the United States and Europe. Active constituents with cur-
able features found in most of ginseng species include ginse-
nosides,  polysaccharides,  peptides,  polyacetylenic  alcohols, 
and fatty acids. Recent studies reported that major active in-
gredients  such  as  ginsenosides  promote  anti-allergic  effects 
and anti-inflammatory effects (21,22). However, few studies 
have investigated on their possibility as potential anti-atopic 
agents.
    In this study, we have investigated the effect of KRG ex-
tracts on the production of TNF-α and IL-8 in human kerati-
nocytes.  In  addition,  to  examine  the  antioxidative  effect  of 
red ginseng extracts, free radical scavenging activity and su-
p e r o x i d e  d i s m u t a s e  ( S O D )  a c t i v i t y  i n  h u m a n  d e r m a l  f i b r o -
blasts  was  measured.
MATERIALS AND METHODS
Preparation of Korean red ginseng (KRG) extracts
Six-year old fresh ginseng was collected from Youngchun in 
Korea (October 2009). KRG extract was prepared by water 
extraction  and  manufactured  by  Coseed  Biopharm  (Korea). 
Briefly, red ginseng was made by steaming fresh ginseng at 
95∼100
oC  for  2  h  and  drying  at  55∼60
oC.  One  hundred 
grams of powdered red ginseng was added to 1 L of distilled 
water, and was extracted at 4
oC for 7 hr. The extraction pro-
cedure was repeated seven times. The extract was filtered us-
ing  400  mash  and  0.45μm  filters.  Sugar  content  and  dry 
weight  of  the  final  extract  was  1.7  brix  and  0.44%,  res-
pectively.
Cell culture
Human keratinocytes (HaCaT) and human dermal fibroblasts 
(HDF-N)  were  maintained  in  Dulbecco’s  Modified  Eagle 
Medium (DMEM) and were supplemented with 10% fetal bo-
vine serum (FBS), 100 U/ml penicillin and 100μg/ml strepto-
mycin at a temperature of 37
oC in a 5% CO 2 humidified in-
cubator  (Sanyo,  Japan).  For  cytoine  production,  cells  were 
detached by vigorous pipetting. After centrifugation, the cells 
were  incubated  (5×10
5  cells/ml)  with  fresh  medium  in 
24-well flat-bottomed tissue culture plates (Corning, NY, USA) 
at  37
oC  in  a  5%  CO2  humidified  incubator  (Sanyo,  Japan). 
Cells were supplemented in the absence or presence of KRG 
extracts and stimulants (1μg/ml lipopolysachharide (LPS) for 
TNF-α and IL-8) for 48 h. Cultures were centrifuged at 300× 
g  for  10  min  to  separate  supernatant  from  cells.
Cell density determination
Cell  numbers  and  viability  were  assessed  by  trypan  blue 
(Sigma, Poole, UK) dye exclusion. Twenty microliters of try-
pan blue solution was mixed with 20μl of cell suspension 
i n  a  m i c r o t u b e  t o  o b t a i n  a  f i n a l  d e n s i t y  o f  0 . 3 −2×10
6 
cells/ml,  and  was  loaded  onto  a  hemocytometer.  The  cells 
that excluded the dye were counted in the standard manner 
within 1∼5 min after mixing of the dye and cell suspension.Effects of Korean Red Ginseng
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MTT assay
To determine the cytotoxic effect of KRG extracts, the viability 
of  HaCaT  and  HDF-N  cells  were  measured  48  h  post- 
treatment. The cytotoxicity was measured by MTT (3-(4,5-di-
methylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide, Sigma, 
P o o l e ,  U K )  a s s a y  c o l o r i m e t r i c  d y e  r e d u c t i o n  m e t h o d .  C e l l s  
(1×10
5 cells/ml) were seeded in 96 well flat-bottomed tissue 
culture plates (Corning, NY, USA) in the absence or presence 
of KRG extracts for 24 h at 37
oC in a 5% CO2 humidified in-
cubator (Sanyo, Japan). At the end of the incubation, 50μl 
of filtered sterilized MTT stock solution was added and the 
plate  was  incubated  for  a  further  4  h.  Dimethylsulfoxide 
(DMSO, Duchefa Biochemie, Netherlands) was added and the 
absorbance  was  detected  using  an  enzyme-linked  im-
munosorbent assay (ELISA) plate reader (Molecular Devices, 
C A .  U S A )  a t  5 7 0  n m .
Measurement of TNF-α and IL-8 secretion
The levels of cytokine produced in the culture supernatants 
were determined by a commercially available ELISA kit ob-
t a i n e d  f r o m  A s s a y  D e s i g n s ,  I n c  ( M I ,  U S A ) .  B r i e f l y ,  s u p e r -
natants were added to the 96-well plates coated with mono-
clonal  antibody  with  specificity  for  human  TNF-α or  IL-8. 
Between subsequent steps in the assay, coated plates were 
washed 4 times with phosphate buffer saline (PBS) containing 
0.05%  (v/v)  Tween-20.  After  exposure  to  medium,  assay 
plates were sequentially exposed to biotin-conjugated anti-cy-
tokine  antibodies  and  detected  by  streptavidine-peroxidase 
anti-rabbit antibody. The plate was developed using 3,3’,5,5’ 
tetramethylbenzidine (TMB) and hydrogen peroxide solution 
and optical density readings at 450 nm was taken using an 
ELISA  plate  reader  (Molecular  Devices,  CA,  USA).
1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scaveng-
ing activity
Various  concentrations  of  KRG  extracts  were  added  to  a 
methanolic  solution  of  DPPH  (0.1  mM)  according  to  the 
method of Bois (23). After being stirred and left for 20 min 
at room temperature, the absorbance of DPPH solution was 
adjusted at 0.700±0.02 with 80% methanol at 517 nm. Fifty 
microliters  of  extracts  or  standard  antioxidant  solution  was 
added to 2.95 ml of methanolic DPPH solution. The mixture 
was shaken vigorously and was left in the dark at 23
oC for 
30 min. The amount of DPPH remaining was determined at 
520  nm,  and  the  radical  scavenging  activity  was  obtained 
from the following equation: Radical scavenging activity (%) 
={(ODcontrol−ODsample)/ODcontrol}×100.
Superoxide dismutase (SOD) activity
S O D  a c t i v i t y  w a s  a s s a y e d  u s i n g  t h e  n i t r o b l u e  t e t r a z o l u m  
(NBT) method of Beauchamp and Fridovich (24). Cells were 
homogenized in 0.05 M sodium carbonate buffer (pH 10.2). 
The assay mixture consisted of 0.05 M sodium carbonite buf-
fer (pH 10.2) containing 3 mM xanthine, 0.75 mM NBT, 3 mM 
EDTA,  1.5  mg/ml  BSA  and  50μl  o f  h o m o g e n a t e .  T h e  r e -
action was initiated by adding 50μl of xanthine oxidase (0.1 
mg/ml) and incubated for 30 min at room temperature. The 
reaction was stopped by adding 6 mM of copper (II) chloride 
and centrifuged at 1,500 rpm for 10 min. The absorbance of 
formazan at 560 nm was then measured in the supernatant. 
The SOD activity was obtained from the following equation: 
SOD  activity  (%)={(ODcontrol−ODsample)/ODcontrol}×100.
Statistical analysis
All values expressed as mean±S.E.M. were obtained from at 
least  five  observations  and  were  compared  using  one  way 
ANOVA followed by Duncan’s multiple range test. Differen-
ces were significant; probability values of ＜0.001, ＜0.01, or 
＜0.05 were considered significant with 99.9%, 99% or 95% 
of  confidence,  respectively.
RESULTS
Cytotoxic effects on HaCaT and HDF-N cells in vitro
Prior to studying the cytotoxic effects of KRG extracts, we de-
termined the optimal dose of LPS. Cells were treated with var-
ious concentrations of LPS and the optimal dose of LPS used 
(1μg/ml) was determined from LPS titration curves (data not 
shown). Cells were treated for 48 h with KRG extracts at the 
indicated  dose  and  the  viability  was  measured  using  MTT 
assay. The control is shown in the bar graph. More than 80% 
of the cells survived at concentrations lower than 1,000μg/ml 
and  1,000μg/ml  in  HaCaT  and  HDF-N  cells,  respectively 
(Figs.  1,  2).
Effect of Korean red ginseng extracts on TNF-α and 
IL-8 secretion in LPS-stimulated HaCaT cells
TNF-α and  IL-8  are  the  major  proinflammatory  cytokines 
produced by keratinocytes, monocytes, and macrophages. As 
shown in Fig. 3, the stimulation of human keratinocytes with 
KRG extracts shifted the LPS-induced cytokine secretion  to-
ward a more immunosuppressive response. In the presence Effects of Korean Red Ginseng
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Figure 1. Cell viability of human keratinocyte cells (HaCaT) when 
treated with Korean red ginseng (KRG) extracts. HaCaT cells were 
treated with various concentrations (100, 200, 400, 800, 1,000, 
2,000, 4,000, 6,000, 8,000, and 10,000μg/ml) of KRG extract for 48
h and the cytotoxicity was measured by MTT assay colorimetric dye 
reduction method. 
Figure 2. Cell viability of human dermal fibroblasts (HDF-N) when
treated with Korean red ginseng (KRG) extracts. HDF-N cells were 
treated with various concentrations (100, 200, 400, 800, 1,000, 
2,000, 4,000, 6,000, 8,000, and 10,000μg/ml) of KRG extract for 48
h and the cytotoxicity was measured by MTT assay colorimetric dye 
reduction method.
Figure 3. Inhibition of TNF-α secretion in HaCaT cells by Korean red
ginseng (KRG) extracts. Cells were stimulated with 1μg/ml LPS and 
was treated with various concentrations of KRG extracts for 48 h. 
Significant difference in comparison with control at *p＜0.05 and **p
＜0.01.
Figure 4. Inhibition of IL-8 secretion in HaCaT cells by Korean red
ginseng (KRG) extracts. Cells were stimulated with 1μg/ml LPS and 
was treated with various concentrations of KRG extracts for 48 h. 
*Significant difference in comparison with control at p＜0.05.
o f  K R G  e x t r a c t s  ( 5 0 ∼1,000μg/ml),  a  decreased  release  of 
TNF-α was  observed  compared  with  LPS  controls.  A  sig-
nificant  inhibition  of  TNF-α was  shown  when  cells  were 
treated with 500 and 1,000μg/ml of KRG extracts (p＜0.05). 
The negative control did not produce any cytokines. In addi-
tion, KRG extracts (50∼1,000μg/ml)  dose-dependently de-
creased IL-8 production in HaCaT cells (Fig. 4). Overall, the 
levels of TNF-α and IL-8 released from LPS-stimulated HaCaT 
cells in the presence of KRG extracts showed a certain im-
munomodulatory effect. Since more than 80% of the cells sur-
vived  at  concentrations  lower  than  1,000μg/ml  in  HaCaT 
cells,  it  seems  unlikely  that  the  inhibition  of  cytokine  pro-
duction  was  due  to  any  cytotoxic  effect  of  KRG  extracts.
Free radical scavenging activity of Korean red 
ginseng extracts
Decoloration of the stable free DPPH radical by antioxidant 
in samples was measured spectrophotometrically (Table I). In Effects of Korean Red Ginseng
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Table I. Free radical scavenging activity of Korean red ginseng 
(KRG) extracts




















Significant difference in comparison with control at *p＜0.05 
and **p＜0.01.
Table II. Free radical scavenging activity of α-tocopherol
Concentration (ug/ml) Free radical scavenging activity (%)
0         0
0.1 −0.2±0.1
1     2.9±0.5
5   16.7±0.4
10   33.9±0.8
Table III. Superoxide dismutase (SOD)-like activities of Korean 
red ginseng (KRG) extracts in human dermal fibroblasts (HDF-N)











*Significant difference in comparison with control at p＜0.05.
addition,  we  compared  these  results  with  those  of  α
-tocopherol (Table II). According to the results, KRG showed 
that it inhibited DPPH formation by 50% at a concentration 
of 11μg/ml (EC50). Samples showed DPPH radical scaveng-
ing  activity  in  a  dose-dependent  manner.
Effect of Korean red ginseng extracts on SOD
In order to investigate whether the antioxidant activity of KRG 
extracts is mediated by an increase in antioxidant enzymes, 
we measured SOD activities in HDF-N cells treated with ex-
tracts  of  KRG  which  had  previously  shown  relatively  high 
DPPH  radical  scavenging  activities  (Table  III).  As  a  result, 
KRG samples dose-dependently increased the antioxidant en-
zyme activity of HDF-N cells. At a dose of 80μg/ml, KRG 
extracts activated SOD level by 51.2%. SOD activities of con-
centrations higher than 60μg/ml were significantly (p＜0.05) 
increased (Table III). Since more than 80% of the cells sur-
vived  at  concentrations  lower  than  1,000μg/ml  in  HDF-N 
cells, it seems unlikely that the induction of antioxidative ac-
tivity  was  due  to  any  cytotoxic  effect  of  KRG  extracts.
DISCUSSION
Atopic  dermatitis  is  common  inflammatory  condition  of  the 
skin, often appears first in early infancy and may persist into 
adulthood.  Although  it  is  not  life  threatening,  it  affects  the 
quality of life (25). For the management of atopic dermatitis, 
early treatment at the onset of symptoms and the prevention 
of recurrence are important. Use of topical or systemic steroid 
is essential for the successful management of atopic dermati-
tis; however, there are controversies regarding its long-term 
use  (26,27).  To  date,  several  natural  substance  based  an-
ti-atopic agents have been topically tested as potential ther-
apeutics for atopic dermatitis (28). Ginseng is known to pos-
sess  various  biological  activities  including  anti-inflammatory 
and  anti-tumor  actions.  The  major  components  of raw  gin-
s e n g  a r e  g i n s e n o s i d e s  ( 2 9 ) .  T h e  anti-allergic  and  anti-in-
flammatory effects of ginsenosides Rh1, anti-allergic effect of 
ginsenosides Rh2, and anti-allergic and anti-contact dermatitis 
activity  of  KRG  saponin  fraction  and  ginsenosides  Rg3,  Rf, 
and Rh2 have also been identified. The anti-allergic proper-
ties of KRG saponin fraction and ginsenosides have strongly 
suggested  their  possibility  as  potential  anti-atopic  agents Effects of Korean Red Ginseng
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(21,30). In this study, we have demonstrated that KRG ex-
tracts significantly suppressed LPS-induced elevation of TNF-α 
and  IL-8  secretion  in  human  keratinocytes  (HaCaT).
    Cultured  human  keratinocytes  produce  TNF-α following 
stimulation with lipopolysaccharide (LPS) (31), which can ac-
tivate neutrophils, eosinophils, and macrophages (32). TNF-α 
induces fever, hypotension, leucopenia, local tissue necrosis, 
PGE2, and collagenase synthesis, fibroblast proliferation, and 
collagen synthesis (8). TNF-α and other proinflammatory cy-
tokines  produced  at the  initiation stage  of atopic  dermatitis 
induce the expression of a variety of chemokines and adhe-
sion  molecules  which  direct  the  recruitment,  proliferation, 
and survival of leukocytes within the skin. KRG extracts sig-
nificantly  suppressed  LPS-induced  elevation  of  TNF-α pro-
duction  in  human  keratinocytes.  Furthermore,  Giustizieri  et 
al. (33) reported that TNF-α is the most potent inducer of 
IL-8, therefore the production of this cytokine in human kera-
tinocytes was also measured. Keratinocytes are the major cell 
population of the epidermis and can be activated to produce 
various chemokines, including IL-8/CXCL8 (34,35). Keratino-
cyte production of IL-8 has been implicated in the pathology 
of skin diseases (36,37). In this study, we confirmed keratino-
cyte-associated  IL-8  production  when  cells  were  stimulated 
with LPS. High levels of IL-8 expression have already been 
implicated in multiple aspects of the pathogenesis of skin dis-
eases, including T-cell and neutrophil chemotaxis and activa-
tion, as well as keratinocyte hyperproliferation (38). In vitro 
studies have shown that IL-8 was the only chemokine con-
stitutively  produced  by  keratinocytes,  and  TNF-α was  the 
most potent inducer of IL-8 (33). Therefore, we can assume 
that the inhibition of TNF-α in LPS-stimulated keratinocytes 
has lead to the decrease of IL-8 production which may lead 
t o  t h e  p r e v e n t i o n  o f   skin  inflammation.
    ROS  produced  by  the  activation  of  primed  inflammatory 
cells have potentially deleterious effects on the biological sys-
tem  as  they  can  damage  proteins,  lipids  and  nucleic  acids 
(39-41). It was reported that the capacity for SOD induction 
in peripheral blood leucocytes in atopic dermatitis patients is 
lower than normal (42). Also, it has previously been shown 
that in extreme oxidative environments, H2O2 inactivates SOD 
and  O2
−  inactivates  the  other  scavenging  enzymes  such  as 
catalase and glutathione peroxidase (43,44). Therefore, it is 
important to look into the SOD activity produced by KRG ex-
tracts to determine whether it can be considered a potential 
agent for atopic dermatitis. As shown in Table III, KRG ex-
t r a c t s  s h o w e d  S O D  a c t i v i t i e s  i n  a  d o s e - d e p e n d e n t  m a n n e r .  
KRG extracts activated SOD level by 51.2% at a dose of 80 
μg/ml and SOD activities of concentrations higher than 60 
μg/ml  were  significantly  (p＜0.05)  elevated.  Since  it  was 
shown that environmentally generated ROS may induce oxi-
dative protein damage in the stratum corneum, leading to the 
disruption of barrier function and exacerbation of atopic der-
matitis (45), we investigated the scavenging activity of KRG 
to determine whether it beneficial to atopic dermatitis. In in-
flammatory  conditions,  activated  macrophages  and  eosino-
phils  produce  ROS  including  O2
−,  H2O2,  HOCl,  and  OH. 
These  in  turn  encourage  more  cell  migration  into  the  area 
by  stimulating  cytokine  release,  adhesion  molecule  ex-
pression  and  complement  activation  (46,47).  We tested the 
radical-scavenging effect of KRG extracts on ROS generated 
by  the  stable  radical  DPPH,  and  as  result,  KRG  extracts 
showed  a  radical-scavenging  activity  in  a  concentration-de-
pendent manner compared to the controls (Table I). EC50 was 
shown at 11μg/ml of KRG, inhibiting the DPPH formation 
by 50%. Our results suggest that KRG extract can reduce the 
level of ROS released from inflammatory cells, which might 
contribute  to  their  anti-inflammatory  action.
    In conclusion, our results demonstrates that KRG extracts 
suppress cytokines including TNF-α and IL-8 in LPS-stimu-
lated human keratinocytes, and also has an antioxidative ef-
fect in human dermal fibroblasts. Based on our findings, KRG 
extracts may be considered a potential agent in the manage-
ment of atopic dermatitis. Further studies are required to elu-
cidate the mechanism of action of KRG extraction on atopic 
dermatitis.
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